Business Description
Quoin Pharmaceuticals is a specialty drug company based in Ashburn, Virginia, focused on developing treatments for rare and serious skin conditions such as Netherton Syndrome, epidermolysis bullosa, and scleroderma. Its lead product, QRX003, is a topical lotion currently in late-stage development, with several other treatments also in progress. Founded in 2018 as a subsidiary of Skinvisible Inc., the company works alongside a number of research and consulting partners to advance its pipeline toward commercialization in the United States.
